United States
Discover how to navigate EU release requirements with confidence. This webinar will discuss the complete pathway to EU batch release, providing practical guidance on importation, GMP testing, QP certification, and accelerating time to market for biologics and advanced therapeutics.
Speakers:
Felix Harion – Scientific Expert, Business Development Manager, Eurofins BioPharma Product Testing Germany
Expanding into Europe requires more than just regulatory approval. Successful market entry depends on the seamless coordination of importation, GMP testing, batch documentation review, and Qualified Person (QP) certification.
Join Eurofins BioPharma Product Testing for an expert-led webinar covering the complete pathway from product importation through analytical testing and final EU batch release. We will discuss practical considerations, common challenges, and proven strategies to accelerate product release while maintaining full regulatory compliance.
Whether you are manufacturing biologics, biosimilars, ADCs, vaccines, peptides, or other advanced therapeutics outside the EU, this webinar will provide valuable insights into the requirements and timelines for entering the European market.
Eurofins BioPharma Product Testing provides comprehensive EU product release support through a network of GMP-compliant laboratories and experienced Qualified Persons.
Our end-to-end solutions include:
By bringing these services together under one coordinated process, we help pharmaceutical manufacturers reduce complexity, maintain compliance, and accelerate product release.
Gain practical insights from industry experts and learn how to navigate EU retesting, batch release, and QP certification with confidence.
📅 Date: 10 Nov, 2026 | 10:30 & 16:30 CEST